Brief: Emcure Pharmaceuticals US FDA Inspection At Emcure's Gujarat Facility
10/10/2025 10:39
Oct 10 (Reuters) - Emcure Pharmaceuticals EMCU.NS: US FDA INSPECTION AT EMCURE'S GUJARAT FACILITY INSPECTION CONCLUDED WITHOUT ANY OBSERVATION Source text: ID:nBSE97Hsxj Further company coverage: EMCU.NS ((Reuters.briefs@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees